This study aimed to analyze changes in QRS duration and cardiothoracic ratio (CTR) following pulmonary valve replacement (PVR) in patients with tetralogy of Fallot (TOF). Methods: Children and adolescents who had previously undergone total repair for TOF (n=67; median age, 16 years) who required elective PVR for pulmonary regurgitation and/or right ventricular out tract obstruction were included in this study. The QRS duration and CTR were measured pre-and postoperatively and postoperative changes were evaluated. Results: Following PVR, the CTR significantly decreased (pre-PVR 57.2%±6.2%, post-PVR 53.8%± 5.5%, P=0.002). The postoperative QRS duration showed a tendency to decrease (pre-PVR 162.7±26.4 msec, post-PVR 156.4±24.4 msec, P=0.124). QRS duration was greater than 180 msec in 6 patients prior to PVR. Of these, 5 patients showed a decrease in QRS duration following PVR; QRS duration was less than 180 msec in 2 patients, and QRS duration remained greater than 180 msec in 3 patients, including 2 patients with diffuse postoperative right ventricular outflow tract hypokinesis. Six patients had coexisting arrhythmias before PVR; 2 patients, atrial tachycardia; 3 patients, premature ventricular contraction; and 1 patient, premature atrial contraction. None of the patients presented with arrhythmia following PVR. Conclusion: The CTR and QRS duration reduced following PVR. However, QRS duration may not decrease below 180 msec after PVR, particularly in patients with right ventricular outflow tract hypokinesis. The CTR and ECG may provide additional clinical information on changes in right ventricular volume and/or pressure in these patients.
Introduction
Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart disease, with an in cidence rate of 5%-7%. 1) Characteristic anatomic features include (1) right ventricular outflow tract (RVOT) stenosis, (2) ventricular septal defect, (3) overriding aortic root, and (4) right ventricular hypertrophy.
24)
Total correction of TOF eliminates the RVOT stenosis and closes the interventricular septal defect. Patients who underwent successful corrective surgery generally are symptom free and show good recovery, but pulmonary regurgitation (PR) may remain after relief of RVOT stenosis. 1, 4) Although PR severity may vary, severe or prolonged PR can in turn lead to RV dilation and functional decline, hypokinesis, and ventricular arrhythmia. 1, 57) These changes require longterm regular followup using chest Xray, electrocardiogram (ECG), and
Statistical analysis
All statistical analyses were performed using IBM SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA), and the results were indicated as mean±standard deviation or median. Comparative analysis was performed using Student t test, and a P value of less than 0.05 was defined as statistically significant.
Results

Demographic data
Of 67 patients analyzed, 22 underwent PVR (Table 1) . Sixteen patients (16 of 22, 73%) needed transannular (TAP) patch insertion at the time of initial TOF correction. Patients were followed up for a median of 14.5 years (range, 6-22 years) from the time of initial TOF correction to PVR. The median age at the time of PVR was 16 years (range, 9-30 years). Eleven patients (11 of 22, 50%) showed RV hypertrophy and diffuse RV hypokinesis on prePVR computed tomography and echocardiography, and 1 had an RVOT aneurysm.
The main reason for PVR was severe PR in 20 and severe PR accompanied by pulmonary stenosis (PS) in 2. Mechanical and tis sue valve were used for PVR in 8 (8 of 22, 36%) and 14 (14 of 22, 64%), respectively. Eleven patients (11 of 22, 50%) needed addition pro cedures with PVR; peripheral pulmonary angioplasty in 6, tricuspid valve repair in 4, and maze operation for atrial tachycardia (AT) in 1. The median duration of followup after PVR was 3.9 years (range, 0.9-8.3 years).
The median age of the 45 patients who did not undergo PVR was 13 years at the latest followup (range, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] ). There were 23 patients (23 of 45, 51%) with TAP at the time of initial TOF correction. The median duration of followup after initial total TOF correction was 11.2 years (range, 6.7-23 years).
echocardiography. ECG and chest Xray can show QRS duration >180 msec and increased cardiothoracic ratio (CTR), respectively.
Pulmonary valve replacement (PVR) for patients with repaired TOF improves signs of heart failure caused by chronic volume overload of the RV. It can decrease RV volume and size, eliminate the propensity for arrhythmia, and decrease the risk of sudden cardiac death. During regular followup after PVR, not only echocardiography but also ECG and chest Xray may show these changes. 8) This study investigated the changes of QRS duration and CTR after PVR using ECG and chest Xray in patients with TOF and severe PR.
Materials and methods
Patients
Among patients who was diagnosed with TOF prior to age 1 and under went total correction, 67 receiving regular followup between Jan uary 2005 and February 2015 for PR or RVOT stenosis were in cluded in the analysis. Enrolled patients were divided into 2 groups such as PVR group and nonPVR group according to need for PVR due to severe PR.
Severe PR were examined using echocardiography defined as abnormal pulmonary valve (distorted or absent leaflets, or annular dilation), RV enlargement, paradoxical septal motion, Color jet which fills RVOT, and/or continuous wave jet density and contour (dense laminar flow with steep deceleration slope and abrupt termi nation). 9, 10) Total correction of TOF involved median sternotomy, followed by patch closure of the interventricular septum through an RV or right atrial approach under cardiopulmonary bypass and circula tory arrest, as well as enlargement of the RV outflow tract and stenotic pulmonary arteries.
11) The timing of PVR for severe PR was determined via 2dimensional echocardiography and cardiac catheterization. For male patients, mechanical valve was chosen first. A 12lead ECG was performed preoperatively and 1 year post operatively, and the QRS duration was analyzed. The ECG was performed at a paper speed of 25 mm/sec, and QRS duration was defined as the interval from the beginning of the Q wave to the end of the S wave, corresponding to the time from ventricular de polarization to activation of all parts of the heart. The longest QRS duration was used for this analysis.
The CTR was calculated from the chest Xray performed at the time of admission for PVR and 1 year postoperatively.
Patient information was retrieved and evaluated with the ap proval of the medical records department and Institutional Review Board at Kyungpook National University Hospital (approval num ber: 201611019). 
Change in CTR
CTR in the PVR and nonPVR groups is shown in Table 2 . CTR was significantly different between the PVR and nonPVR group (P=0.001), and reduced from prePVR to postPVR (P=0.002).
Change in QRS duration
QRS duration was significantly different between the PVR and noPVR group (Table 2) (P=0.001). Compared with prePVR QRS duration, postPVR QRS duration was decreased, but not signifi cantly (P=0.124).
There were 6 patients with prePVR QRS duration >180 msec (Table 3 ). Among them, 5 patients showed reduction of QRS dura tion after PVR; postPVR QRS duration <180 msec in 2 and post PVR QRS duration >180 msec in 3. There was 1 patient with pre PVR and postPVR QRS duration >180 msec without change after PVR. Of the 4 patients with postPVR QRS duration >180 msec, 2 had diffuse RVOT hypokinesis postoperatively.
There were 16 patients with prePVR QRS duration <180 msec. Among them, 6 patients showed reduction of QRS duration after PVR and had postPVR QRS duration <180 msec. Although 7 patients showed increase or no change of postPVR QRS duration, they had postPVR QRS duration <180 msec. Three patients with prePVR QRS duration <180 msec showed postPVR QRS duration >180 msec. They already had trifascicular block, and needed redo PVR or concurrent pulmonary angioplasty at the time of PVR.
Change in arrhythmias
Six patients showed coexisting arrhythmias before PVR. There were AT in 2, premature ventricular contractions (PVCs) in 3, and nonconducted premature atrial contractions (PACs) and left ven tricular systolic dysfunction in 1.
One patient with PVC showed prePVR QRS duration > 180 msec and postPVR QRS duration <180 msec. Four patients (AT in 2 and PVC in 2) showed prePVR QRS duration <180 msec and reduction of postPVR QRS duration. One patient with PAC did not show any change between prePVR and postPVR.
There was no patient with arrhythmia confirmed by ECG after PVR, and no reported cases of arrhythmia recurrence by holter moni toring and symptoms, chest pain, or additional surgery during followup.
Discussion
We hypothesized that increased RV volume in repaired TOF and severe PR would decrease after PVR, and CTR on chest Xray and QRS duration on ECG would reflect these changes. From the present study, we found that postPVR CTR on chest Xray showed significant decrease. In addition, PVR could make reduction of QRS duration for patients with prePVR QRS duration >180 msec and improvement of arrhythmia, although some patients still showed postPVR QRS duration >180 msec.
ECG can be a simple yet clinically relevant indicator for RV func tion and longterm prognosis in patients who have undergone TOF correction. In previous studies, QRS duration on ECG was related to the degree of RV hypertrophy, arrhythmia, and sudden death. In particular, QRS duration >180 msec was associated with ventricular tachycardia, RV dilatation, and sudden death. 1, 4, 10) Moreover, pati ents who underwent surgery for TOF showed increased longterm mortality due to ventricular arrhythmia. 12) Previous studies reported that patients with severe PR who under went surgical TOF correction showed postPVR improvement in arrhythmia as well as a decrease in QRS duration >180 msec. 13, 14) However, recent studies show that the relationship between PVR and QRS duration is not clear. 5, 15, 16) QRS duration >180 msec prior to PVR that did not decrease after PVR was associated with symptomatic heart failure, repeat PVR, ventricular arrhythmia, and death. 17) The present study showed that PVR was related with decrease in post PVR QRS duration in 50% of patients and resolution of arrhythmia. However, 67% of patients with prePVR QRS duration >180 msec had still postPVR QRS duration >180 msec. They showed prePVR CTR greater than 60%, or decreased cardiac function associated with ventricular arrhythmia and likely did not show normal recovery of RV function or volume postoperatively. The results of the present and previous studies indicate that despite elimination of PR and decreased RV volume loading after Values are presented as number. PVR, pulmonary valve replacement.
PVR, severe and prolonged PR leads to irreversible damage to RV myocytes due to volume overload and inhibits recovery of RV func tion to a normal level. Another study proposed that prolonged QRS duration is related to infundibular disease due to local damage from TOF, rather than RV dysfunction. 18) A damaged RVOT affects postoperative ventricular remodeling, RV function, and dyssynchrony of ventri cular con traction and causes heterogeneous conduction. This can lead to persistent risk of arrhythmia in TOF patients with car diomyocyte damage and tissue remodeling due to preoperative cyanosis, ven tricular pressure, or volume loading. 15, 16, 19) In other words, PVR plays a role in decreasing RV volume loading but does not alleviate RVOT pathology, therefore may not decrease QRS duration. 5, 16, 19, 20) In the present study, patients who showed increase or no change of post PVR QRS duration underwent infundibulec tomy and TAP. They showed RV hypertrophy, severe PR, and diffuse RV hypokinesis on preoperative computed tomography and echocardiography, and 1 had an RVOT aneurysm. Therefore, current TOF corrective surgery is focused on the RV infundibulum and pulmonary valve preservation. This is probably because these are important factors leading to arrhythmia and sudden death, as shown in this study. The limitations of this study include the small sample size and retrospective study design. We did not perform RV volume mea surement using cardiac magnetic resonance imaging (MRI) or 3dimensional echocardiography routinely. It was not able to com pare results between MRI or echocardiogram and CTR and ECG. The possibility of bias due to the timing of PVR after TOF correction and remnant pathology or symptoms cannot be ignored.
In conclusion, CTR and QRS duration tend to reduce after PVR. However, the absence of a reduction in QRS duration <180 msec after PVR may be occurred, especially in patients with RVOT hypo kinesis. Although cardiac MRI is preferred for the analysis of RV volume and function in patients with repaired TOF, CTR on chest X ray and QRS duration on 12 lead ECG are easily evaluated in clinical practice, and these may provide additional clinical infor mation reflecting changes in RV volume and/or pressure.
